Gregory J. Bix,Sarah Wright,Irene Griswold-Prenner
申请号：
US13519949
公开号：
US20130036481A1
申请日:
2011.01.06
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimers disease. Methods of using DV, LG3 and related molecules in treatment of amyloidogenic diseases, particularly Alzheimers disease, are provided.
